ENT Disorder Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 69 pages | ID: E2F5DF0559B3EN
Market Monitor Global

Abstracts

ENT is a medical abbreviation for ears, nose and throat.

This report contains market size and forecasts of ENT Disorder Treatment in Global, including the following market information:

Global ENT Disorder Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global ENT Disorder Treatment market was valued at 7110.8 million in 2021 and is projected to reach US$ 8445.7 million by 2028, at a CAGR of 2.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tonsillitis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of ENT Disorder Treatment include AstraZeneca, Novartis, Pfizer, Mylan, Teva Pharmaceutical, GlaxoSmithKline, Otonomy, Merck and Reddy’s and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ENT Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global ENT Disorder Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global ENT Disorder Treatment Market Segment Percentages, by Type, 2021 (%)

• Tonsillitis
• Ear Infections
• Sinus Infections
• Sleep Apnea

Global ENT Disorder Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global ENT Disorder Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Others

Global ENT Disorder Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global ENT Disorder Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies ENT Disorder Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies ENT Disorder Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Novartis
• Pfizer
• Mylan
• Teva Pharmaceutical
• GlaxoSmithKline
• Otonomy
• Merck
• Reddy’s
• Allergen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 ENT Disorder Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global ENT Disorder Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ENT DISORDER TREATMENT OVERALL MARKET SIZE

2.1 Global ENT Disorder Treatment Market Size: 2021 VS 2028
2.2 Global ENT Disorder Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top ENT Disorder Treatment Players in Global Market
3.2 Top Global ENT Disorder Treatment Companies Ranked by Revenue
3.3 Global ENT Disorder Treatment Revenue by Companies
3.4 Top 3 and Top 5 ENT Disorder Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies ENT Disorder Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 ENT Disorder Treatment Players in Global Market
  3.6.1 List of Global Tier 1 ENT Disorder Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 ENT Disorder Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global ENT Disorder Treatment Market Size Markets, 2021 & 2028
  4.1.2 Tonsillitis
  4.1.3 Ear Infections
  4.1.4 Sinus Infections
  4.1.5 Sleep Apnea
4.2 By Type - Global ENT Disorder Treatment Revenue & Forecasts
  4.2.1 By Type - Global ENT Disorder Treatment Revenue, 2017-2022
  4.2.2 By Type - Global ENT Disorder Treatment Revenue, 2023-2028
  4.2.3 By Type - Global ENT Disorder Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global ENT Disorder Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Ambulatory Surgical Centers
  5.1.5 Home Care Settings
  5.1.6 Others
5.2 By Application - Global ENT Disorder Treatment Revenue & Forecasts
  5.2.1 By Application - Global ENT Disorder Treatment Revenue, 2017-2022
  5.2.2 By Application - Global ENT Disorder Treatment Revenue, 2023-2028
  5.2.3 By Application - Global ENT Disorder Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global ENT Disorder Treatment Market Size, 2021 & 2028
6.2 By Region - Global ENT Disorder Treatment Revenue & Forecasts
  6.2.1 By Region - Global ENT Disorder Treatment Revenue, 2017-2022
  6.2.2 By Region - Global ENT Disorder Treatment Revenue, 2023-2028
  6.2.3 By Region - Global ENT Disorder Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America ENT Disorder Treatment Revenue, 2017-2028
  6.3.2 US ENT Disorder Treatment Market Size, 2017-2028
  6.3.3 Canada ENT Disorder Treatment Market Size, 2017-2028
  6.3.4 Mexico ENT Disorder Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe ENT Disorder Treatment Revenue, 2017-2028
  6.4.2 Germany ENT Disorder Treatment Market Size, 2017-2028
  6.4.3 France ENT Disorder Treatment Market Size, 2017-2028
  6.4.4 U.K. ENT Disorder Treatment Market Size, 2017-2028
  6.4.5 Italy ENT Disorder Treatment Market Size, 2017-2028
  6.4.6 Russia ENT Disorder Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries ENT Disorder Treatment Market Size, 2017-2028
  6.4.8 Benelux ENT Disorder Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia ENT Disorder Treatment Revenue, 2017-2028
  6.5.2 China ENT Disorder Treatment Market Size, 2017-2028
  6.5.3 Japan ENT Disorder Treatment Market Size, 2017-2028
  6.5.4 South Korea ENT Disorder Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia ENT Disorder Treatment Market Size, 2017-2028
  6.5.6 India ENT Disorder Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America ENT Disorder Treatment Revenue, 2017-2028
  6.6.2 Brazil ENT Disorder Treatment Market Size, 2017-2028
  6.6.3 Argentina ENT Disorder Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa ENT Disorder Treatment Revenue, 2017-2028
  6.7.2 Turkey ENT Disorder Treatment Market Size, 2017-2028
  6.7.3 Israel ENT Disorder Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia ENT Disorder Treatment Market Size, 2017-2028
  6.7.5 UAE ENT Disorder Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca ENT Disorder Treatment Major Product Offerings
  7.1.4 AstraZeneca ENT Disorder Treatment Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis ENT Disorder Treatment Major Product Offerings
  7.2.4 Novartis ENT Disorder Treatment Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer ENT Disorder Treatment Major Product Offerings
  7.3.4 Pfizer ENT Disorder Treatment Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Mylan
  7.4.1 Mylan Corporate Summary
  7.4.2 Mylan Business Overview
  7.4.3 Mylan ENT Disorder Treatment Major Product Offerings
  7.4.4 Mylan ENT Disorder Treatment Revenue in Global Market (2017-2022)
  7.4.5 Mylan Key News
7.5 Teva Pharmaceutical
  7.5.1 Teva Pharmaceutical Corporate Summary
  7.5.2 Teva Pharmaceutical Business Overview
  7.5.3 Teva Pharmaceutical ENT Disorder Treatment Major Product Offerings
  7.5.4 Teva Pharmaceutical ENT Disorder Treatment Revenue in Global Market (2017-2022)
  7.5.5 Teva Pharmaceutical Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline ENT Disorder Treatment Major Product Offerings
  7.6.4 GlaxoSmithKline ENT Disorder Treatment Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 Otonomy
  7.7.1 Otonomy Corporate Summary
  7.7.2 Otonomy Business Overview
  7.7.3 Otonomy ENT Disorder Treatment Major Product Offerings
  7.7.4 Otonomy ENT Disorder Treatment Revenue in Global Market (2017-2022)
  7.7.5 Otonomy Key News
7.8 Merck
  7.8.1 Merck Corporate Summary
  7.8.2 Merck Business Overview
  7.8.3 Merck ENT Disorder Treatment Major Product Offerings
  7.8.4 Merck ENT Disorder Treatment Revenue in Global Market (2017-2022)
  7.8.5 Merck Key News
7.9 Reddy’s
  7.9.1 Reddy’s Corporate Summary
  7.9.2 Reddy’s Business Overview
  7.9.3 Reddy’s ENT Disorder Treatment Major Product Offerings
  7.9.4 Reddy’s ENT Disorder Treatment Revenue in Global Market (2017-2022)
  7.9.5 Reddy’s Key News
7.10 Allergen
  7.10.1 Allergen Corporate Summary
  7.10.2 Allergen Business Overview
  7.10.3 Allergen ENT Disorder Treatment Major Product Offerings
  7.10.4 Allergen ENT Disorder Treatment Revenue in Global Market (2017-2022)
  7.10.5 Allergen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. ENT Disorder Treatment Market Opportunities & Trends in Global Market
Table 2. ENT Disorder Treatment Market Drivers in Global Market
Table 3. ENT Disorder Treatment Market Restraints in Global Market
Table 4. Key Players of ENT Disorder Treatment in Global Market
Table 5. Top ENT Disorder Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global ENT Disorder Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global ENT Disorder Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies ENT Disorder Treatment Product Type
Table 9. List of Global Tier 1 ENT Disorder Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 ENT Disorder Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global ENT Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - ENT Disorder Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - ENT Disorder Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global ENT Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - ENT Disorder Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - ENT Disorder Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global ENT Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global ENT Disorder Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global ENT Disorder Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America ENT Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America ENT Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe ENT Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe ENT Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia ENT Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia ENT Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America ENT Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America ENT Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa ENT Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa ENT Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca ENT Disorder Treatment Product Offerings
Table 32. AstraZeneca ENT Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis ENT Disorder Treatment Product Offerings
Table 35. Novartis ENT Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer ENT Disorder Treatment Product Offerings
Table 38. Pfizer ENT Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Mylan Corporate Summary
Table 40. Mylan ENT Disorder Treatment Product Offerings
Table 41. Mylan ENT Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Teva Pharmaceutical Corporate Summary
Table 43. Teva Pharmaceutical ENT Disorder Treatment Product Offerings
Table 44. Teva Pharmaceutical ENT Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline ENT Disorder Treatment Product Offerings
Table 47. GlaxoSmithKline ENT Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Otonomy Corporate Summary
Table 49. Otonomy ENT Disorder Treatment Product Offerings
Table 50. Otonomy ENT Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Merck Corporate Summary
Table 52. Merck ENT Disorder Treatment Product Offerings
Table 53. Merck ENT Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Reddy’s Corporate Summary
Table 55. Reddy’s ENT Disorder Treatment Product Offerings
Table 56. Reddy’s ENT Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Allergen Corporate Summary
Table 58. Allergen ENT Disorder Treatment Product Offerings
Table 59. Allergen ENT Disorder Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. ENT Disorder Treatment Segment by Type in 2021
Figure 2. ENT Disorder Treatment Segment by Application in 2021
Figure 3. Global ENT Disorder Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global ENT Disorder Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global ENT Disorder Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by ENT Disorder Treatment Revenue in 2021
Figure 8. By Type - Global ENT Disorder Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global ENT Disorder Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global ENT Disorder Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America ENT Disorder Treatment Revenue Market Share, 2017-2028
Figure 12. US ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe ENT Disorder Treatment Revenue Market Share, 2017-2028
Figure 16. Germany ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia ENT Disorder Treatment Revenue Market Share, 2017-2028
Figure 24. China ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America ENT Disorder Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa ENT Disorder Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE ENT Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca ENT Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis ENT Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer ENT Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mylan ENT Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Pharmaceutical ENT Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline ENT Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Otonomy ENT Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck ENT Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Reddy’s ENT Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Allergen ENT Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)